Major Depressive Disorder

Just 7 other states, and the District of Columbia, have passed such a law before. The bill's parameters are similar to that of Hawaii's, which passed its own law last year.

The 60-hour intravenous therapy becomes the first drug indicated for postpartum depression.

A review of suicide prediction models reveals limited practical application on larger populations.

Despite previous observations that high-quality diet correlates to lower depression symptoms, new results paint a different picture.

One of the pioneer investigators of ketamine for depression explains what its recent approval for a severe form of the condition means for patients running out of options.

The therapy becomes the first novel mechanism of action-driven drug approved for depression in 30 years.

The prevalence of anxiety, depression, and ADD was higher in patients with this excessive sweating disorder than the general population.

A large retrospective study of patients with acne found no significant association between isotretinoin exposure and depression.

Anxiety and depression each contribute to impaired cognition in patients with MS and other immune-mediated disorders, a new study shows.

Ketamine looks promising as a potential therapy for treatment-resistant depression. The problem is that more research is needed to understand it.

A study of medical school applicants through their education showed those more expected to become a doctor by their parents are more likely to feel the strains of becoming one.

If approved, Spravato would become the first novel mechanism of action in 30 years to treat major depressive disorder.

The US Preventive Services Task Force has recommended that clinicians refer pregnant and postpartum persons who are at risk of depression for counseling services.

Trazodone is a depression drug, but it blocks the integrated stress response, so it may be a good candidate for ALS.

Physicians on the front lines of care should be empowered to consider alternative treatment options for patients in significant need.

A new cohort analysis shows patients switching or adding on the antipsychotic drug are not at a worse risk of suicide or other adverse events.

Hilary Baldwin, MD, debunks the myths behind the nodular acne therapy she claims is a miracle drug.

Why certain age-related factors particularly impact the mental health of women at the age their menopause symptoms appear.

The antipsyhoctic could receive a new indication in 2019, and though the field of bipolar disorder care is far from perfect, it should improve with this addition.

The study focused on patients with bipolar or depressive disorder.

A retrospective study showed which patients with substance use disorder may have less successful antiepileptic drug treatment.

Patients treated with SAGE-217 had significantly improved depression scores and were more likely to achieve remission than those receiving placebo.

Investigator Anita Clayton, MD, shares insights into the new vortioxetine data and its implications for patients with depression and treatment-emergent sexual dysfunction.

About half of all MS patients experience an episode of depression during their lifetimes, but most interventions are drug-related or psychiatric.

Most of the patients in the study were taking concomitant antidepressants and/or antipsychotics, and mood disorders remained stable during treatment with valbenazine.